UNSPSC 51272000: Anaesthetic barbiturates

Anaesthetics based on a class of chemicals derived from barbituric acid or thiobarbituric acid

UNSPSC 51272000 Anaesthetic barbiturates is a Class code that in recent state and local procurement activity covers a much broader range of pharmaceutical products and pharmacy benefit management services than the code name suggests. State and local governments are soliciting naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and direct-to-manufacturer prescription program capabilities. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, which serves participating state and local facilities across multiple jurisdictions including Oregon). The scope of work ranges from procurement of finished pharmaceuticals for community health initiatives to establishment of master contracts with pharmaceutical manufacturers and wholesalers serving state employee health plans and Medicaid programs.

Recent activity shows geographic spread across Florida, Texas, and Minnesota, with multistate reach through cooperative purchasing vehicles. Representative opportunities include Seminole County's competitive bid (IFB 60459723LAS, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas HHS Commission's Request for Information (HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers with award effective July 1, 2026. The MMCAP procurement emphasizes cGMP and Drug Supply Chain Security Act compliance, EDI capability, and tiered pricing models, while the Texas RFI focuses on market intelligence for direct contracting and outcomes-based agreements outside traditional PBM structures.